June 26, 2012
Tennessee drugmaker Cumberland Pharmaceuticals Inc. launched a patent infringement suit in Delaware federal court Tuesday challenging an effort by Sagent Pharmaceuticals Inc. and Sagent Agila LLC to win U.S. regulatory approval for a generic version of acetaminophen-overdose treatment Acetadote.